Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 2
2009 2
2011 1
2013 1
2014 1
2015 1
2016 2
2018 2
2019 3
2020 3
2021 5
2022 12
2023 9
2024 10
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP, Sutera P, Jing Y, Gao R, Rothman E, Day H, Chang D, Dirix P, Armstrong AJ, Campbell B, Lopez Campos F, Berenguer M, Ramotar M, Conde-Moreno A, Berlin A, Bosetti DG, Corcoran N, Koontz B, Mercier C, Siva S, Pryor D, Ost P, Huynh MA, Kroeze S, Stish B, Kiess A, Trock B, Tran PT, Gillessen S, Sweeney C. Deek MP, et al. Among authors: huynh ma. Eur Urol Oncol. 2024 Dec;7(6):1403-1410. doi: 10.1016/j.euo.2024.03.010. Epub 2024 Apr 3. Eur Urol Oncol. 2024. PMID: 38570239
Role of Metastasis-Directed Therapy in Genitourinary Cancers.
Lee KN, Huynh MA. Lee KN, et al. Among authors: huynh ma. Curr Treat Options Oncol. 2024 May;25(5):605-616. doi: 10.1007/s11864-024-01199-z. Epub 2024 Apr 4. Curr Treat Options Oncol. 2024. PMID: 38573430 Review.
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.
Morris ZS, Demaria S, Monjazeb AM, Formenti SC, Weichselbaum RR, Welsh J, Enderling H, Schoenfeld JD, Brody JD, McGee HM, Mondini M, Kent MS, Young KH, Galluzzi L, Karam SD, Theelen WSME, Chang JY, Huynh MA, Daib A, Pitroda S, Chung C, Serre R, Grassberger C, Deng J, Sodji QH, Nguyen AT, Patel RB, Krebs S, Kalbasi A, Kerr C, Vanpouille-Box C, Vick L, Aguilera TA, Ong IM, Herrera F, Menon H, Smart D, Ahmed J, Gartrell RD, Roland CL, Fekrmandi F, Chakraborty B, Bent EH, Berg TJ, Hutson A, Khleif S, Sikora AG, Fong L. Morris ZS, et al. Among authors: huynh ma. Lancet Oncol. 2025 Mar;26(3):e152-e170. doi: 10.1016/S1470-2045(24)00656-9. Lancet Oncol. 2025. PMID: 40049206 Review.
50 results